Cambridge Investment Research Advisors »

Briacell Therapeutics Corp shares owned by Cambridge Investment Research Advisors

Quarter-by-quarter ownership of Briacell Therapeutics Corp (BCTX) shares owned by Cambridge Investment Research Advisors from 13F filings

Historical chart of Cambridge Investment Research Advisors investment in Briacell Therapeutics Corp

Tip: Access up to 7 years of quarterly data

All positions including Briacell Therapeutics Corp held by Cambridge Investment Research Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Briacell Therapeutics Corp by Cambridge Investment Research Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $20k 16k 1.23

More positions owned by Cambridge Investment Research Advisors

Apple Inc Com (AAPL)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
NVIDIA Corporation (NVDA)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr Core S&p500 Etf (IVV)
Vanguard Index Fds Total Stk Mkt (VTI)
Microsoft Corp Com (MSFT)
Amazon Com Inc Com (AMZN)
Vanguard Star Fds Vg Tl Intl Stk F (VXUS)
SPDR S&p 500 Etf Tr Tr Unit (SPY)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Pacer Fds Tr Us Cash Cows 100 (COWZ)
Vanguard Bd Index Fds Total Bnd Mrkt (BND)
Schwab Strategic Tr Us Dividend Eq (SCHD)
Vanguard Index Fds Value Etf (VTV)

View all positions for Cambridge Investment Research Advisors

Top funds holding Briacell Therapeutics Corp

Redmond Asset Management
Vontobel Holding
Hrt Financial
Citadel Advisors
Onyx Bridge Wealth Group
Group One Trading
Summit Trail Advisors
LPL Financial
Cambridge Investment Research Advisors
HighTower Advisors
Concord Wealth Partners
Susquehanna International
National Bank Of Canada /fi/
Royal Bank of Canada
TD Waterhouse Canada

View all funds holding Briacell Therapeutics Corp